Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (221-230 of 254) with videos related to

Pageof 26
Sort By:
Blood|October 17, 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert PanelC Michel Zwaan, Sarah K Tasian, Richard Aplenc, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Comprehensive Transcriptome Profiling of Cryptic <i>CBFA2T3-GLIS2</i> Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML StudyJenny L Smith, Rhonda E Ries, Tiffany Hylkema, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
JAMA Network Open|June 23, 2025
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid LeukemiaRichard J Marrero, Vivek M Shastri, Deedra Nicolet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
The Lancet. Haematology|July 23, 2022
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Yimei Li, et al.
Cancer Medicine|April 4, 2024
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity researchHaley Newman, Yimei Li, Yuan-Shung V Huang, et al.
Nature Communications|September 19, 2022
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemiaBenjamin J Huang, Jenny L Smith, Jason E Farrar, et al.
Frontiers in Cardiovascular Medicine|December 18, 2023
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapyKasey J Leger, Nora Robison, Hari K Narayan, et al.
Pageof 26

Showing results (221-230 of 254) with videos related to

Sort By:
Pageof 26
Blood|October 17, 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert PanelC Michel Zwaan, Sarah K Tasian, Richard Aplenc, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Comprehensive Transcriptome Profiling of Cryptic <i>CBFA2T3-GLIS2</i> Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML StudyJenny L Smith, Rhonda E Ries, Tiffany Hylkema, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
JAMA Network Open|June 23, 2025
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid LeukemiaRichard J Marrero, Vivek M Shastri, Deedra Nicolet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
The Lancet. Haematology|July 23, 2022
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Yimei Li, et al.
Cancer Medicine|April 4, 2024
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity researchHaley Newman, Yimei Li, Yuan-Shung V Huang, et al.
Nature Communications|September 19, 2022
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemiaBenjamin J Huang, Jenny L Smith, Jason E Farrar, et al.
Frontiers in Cardiovascular Medicine|December 18, 2023
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapyKasey J Leger, Nora Robison, Hari K Narayan, et al.
Pageof 26